Updated:
New Jersey's Technology Business Tax Certificate Transfer Program
New Jersey's Technology Business Tax Certificate Transfer Program lets tech and biotech firms sell NOLs and R&D credits for cash, administered by the...
New Jersey's Technology Business Tax Certificate Transfer Program
The Technology Business Tax Certificate Transfer Program (the NOL Program) was established by the New Jersey Economic Development Authority to address a structural gap: young tech and biotech firms generate NOLs and R&D tax credits but have no taxable income to offset them. The program lets eligible companies sell up to $15 million in tax benefits per year to unrelated corporations that can use them, effectively monetizing otherwise stranded assets. Applicants must be certified as technology or biotechnology businesses with at most 225 employees and concentrate on research and development. The program has transferred over $1 billion in benefits since inception, with 100+ companies participating annually (per NJEDA public filings). Funds raised can be used for equipment, personnel, or other operational costs. The program is capped at $10 million per participating company per year, with priority given to qualifying microbusinesses. No state guarantee backs transferred credits. The cash from sale is received net of a 5% state fee. Program data is published annually by the NJEDA. Assets are managed by a designated program administrator within the NJEDA. This structure differs from standard tax credit exchanges in that it centralizes approval and provides an annual auction-style market. Eligible corporations are limited to those filing New Jersey corporation business taxes. The program operates as a fiscal stimulus for the state's innovation economy.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
—
Corporate office
United States
Sector focus
Frequently asked questions
Who can sell tax benefits under the NOL Program?
Any New Jersey-based technology or biotechnology corporation with no more than 225 employees, primarily engaged in R&D, can apply for certification to sell up to $15 million in NOLs or R&D credits per year.
How much cash can a company raise through the program?
The program caps each participant at $10 million in transferred benefits annually. Priority is given to microbusinesses with fewer than 10 employees. The cash received is the transfer price net of a 5% state fee.
Who purchases the tax credits?
Any corporation filing New Jersey corporation business taxes, with a state tax liability, can purchase transferred credits. Purchasers receive the credits to reduce their own tax liability.
Is there a secondary market or resale?
No. Credits can only be transferred directly from the seller to a qualified buyer through the program. They cannot be resold or further transferred after purchase.
What types of companies use the program?
Mainly early-stage biotech, pharmaceuticals, medical devices, software, and other tech firms that burn cash on R&D without generating taxable income. Over 200 unique participants have used the program since inception.
How does the program compare to similar tax credit exchanges?
It is one of the most structured state-level NOL monetization programs in the US. Unlike pure transferability in markets like Texas, New Jersey's program requires full NJEDA approval, limits to in-state tech/biotech firms, and imposes employee and revenue caps.
Does the NJEDA guarantee the transferred credits?
No. The state does not guarantee the credits. Buyers assume the risk that the sold benefits are valid. The program administrator audits eligibility but is not an insurance entity.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: